Cardiovascular complications of immunosuppressive agents in renal transplant recipients

Area of Science:

• Nephrology
• Cardiology
• Pharmacology

Background:

• Cardiovascular events are the primary cause of graft loss in transplant recipients.
• Transplant patients exhibit high rates of hypertension, hyperlipidemia, and new-onset diabetes mellitus.
• Native kidney disease and recurrent renal disease can exacerbate cardiovascular risk.

Purpose of the Study:

• To highlight the significant impact of cardiovascular events on graft survival.
• To discuss the prevalence and multifactorial etiology of post-transplant cardiovascular risk factors.
• To emphasize the critical role of drug interactions in managing cardiovascular risk in transplant recipients.

Main Methods:

• Review of existing data on cardiovascular events in transplant patients.
• Analysis of the prevalence and contributing factors of hypertension, hyperlipidemia, and diabetes post-transplantation.
• Evaluation of drug-drug interactions involving immunosuppressive agents and cardiovascular medications.

Main Results:

• Cardiovascular disease is the leading cause of graft loss in functioning transplants.
• Hypertension, hyperlipidemia, and new-onset diabetes are highly prevalent post-transplant.
• Drug interactions and adverse reactions significantly complicate treatment decisions.

Conclusions:

• Effective management of cardiovascular risk factors is crucial for graft survival.
• A multifactorial approach is needed to address post-transplant cardiovascular complications.
• Careful selection of medications, considering potential drug interactions, is essential for transplant recipients.